Cochlear Partners with Everseat to Provide Mobile Scheduling App to Cochlear Clinic Partners

CENTENNIAL, Colo., Jan. 15, 2015 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today that it has entered into a multi-year agreement with the rapidly growing technology startup, Everseat, to provide an all new mobile scheduling platform to its cochlear implant clinic partners. Everseat is a dynamic waitlist that helps improve customer experience by helping organizations and consumers book last minute appointments through an easy-to-use mobile app.

Read More

Transatlantic Partnership Offers Turnkey Solution for Meeting New European Regulatory Demands for Post-market Outcomes Data

ZURICH, MADISON, WI, and NEW YORK: September 8, 2014 — Three companies—one European, two American—have teamed up to enable European manufacturers of implantable ophthalmic devices to comply with anticipated regulatory demands for ongoing post-market outcomes data.

Read More